Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

BACKGROUND: Pancreatic carcinoma remains a treatment-refractory cancer with a poor prognosis. Here, we compared anti-EGF receptor and anti-HER2 monoclonal antibodies (2mAbs) injections with standard gemcitabine treatment on human pancreatic carcinoma xenografts. MATERIALS AND METHODS: Nude mice, bea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Larbouret, Christelle, Robert, Bruno, Bascoul-Mollevi, Caroline, Penault-Llorca, Frédérique, Ho-Pun-Cheung, Alexandre, Morisseau, Sébastien, Navarro-Teulon, Isabelle, Mach, Jean-Pierre, Pèlegrin, André, Azria, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508938/
https://ncbi.nlm.nih.gov/pubmed/19889608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp496
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak